Background
==========

Amino-terminal pro-peptide of type III pro-collagen (PIIINP), collagen IV (CIV), laminin (LN), and hyaluronic acid (HA) are 4 major serum markers for the non-invasive assessment of liver fibrosis \[[@b1-medscimonit-22-2720]--[@b4-medscimonit-22-2720]\]. Numerous studies have confirmed their diagnostic performance. Some examples have been shown as follows. In 1996, Murawaki et al. demonstrated a close relationship of elevated HA with the severity of liver fibrosis in patients with chronic viral liver diseases \[[@b5-medscimonit-22-2720]\]. In 2000, Plevris et al. found that HA alone could reliably identify the presence of liver cirrhosis in patients with chronic liver diseases of mixed etiologies \[[@b6-medscimonit-22-2720]\]. In 2000, the consensus interferon study group also found that HA alone may be effective in non-invasively assessing the degree of liver fibrosis and cirrhosis in patients with chronic hepatitis C virus infection \[[@b7-medscimonit-22-2720]\]. In 2001, Murawaki et al. suggested the usefulness of PIIINP and HA for staging liver fibrosis in chronic hepatitis C \[[@b8-medscimonit-22-2720]\]. In 2002, Xie et al. confirmed the relationship of HA and CIV with the degree of hepatic fibrosis in patients with chronic viral hepatitis \[[@b9-medscimonit-22-2720]\]. In 2004, Patel et al. found that HA in combination with tissue inhibitor of matrix metalloproteinase 1 and alpha 2-macroglobulin can reliably differentiate between moderate/severe and no/mild fibrosis in patients with chronic hepatitis C infection \[[@b10-medscimonit-22-2720]\]. In 2004, the European Liver Fibrosis Group reported that HA and PIIINP in combination with age and tissue inhibitor of matrix metalloproteinase 1 can accurately identify the absence of liver fibrosis \[[@b11-medscimonit-22-2720]\]. In 2005, Cale et al. reported that HA in combination with platelet count, prothrombin index, aspartate aminotransferase, alpha 2-macroglobulin, urea, and age can predict the presence of clinically significant fibrosis in patients with viral hepatitis; HA in combination with prothrombin index, alpha 2-macroglobulin, and age could predict the presence of clinically significant fibrosis in patients with alcoholic liver diseases; HA in combination with gamma-glutamyltransferase, bilirubin, platelet count, and apolipoprotein A1 could predict the area of fibrosis in patients with viral hepatitis; and HA in combination with prothrombin index, alpha 2-macroglobulin, and platelets could predict the area of fibrosis in patients with alcoholic liver diseases \[[@b12-medscimonit-22-2720]\]. In 2011, Seven et al. confirmed the correlation of PIIINP, CIV, LN, and HA with advanced fibrosis in patients with chronic hepatitis B and D \[[@b13-medscimonit-22-2720]\]. In 2015, El-Mezayen et al. found that CIV and LN in combination with aspartate aminotransferase-to-platelet ratio index and albumin can be used to identify a very low risk of significant fibrosis in patients with chronic hepatitis C virus infection \[[@b14-medscimonit-22-2720]\]. Theoretically, the grade of liver fibrosis is positively associated with the severity of liver dysfunction, thereby influencing the survival conditions. However, it remains unclear whether serum liver fibrosis markers can predict the prognosis of patients with liver cirrhosis. We conducted the present prospective observational study to explore this issue.

Material and Methods
====================

This was a prospective observational study, which was registered with clinicaltrials.gov (NCT02335073). The study was conceived by 2 researchers (XSQ and XZG). The study protocol was written by XSQ, discussed with our study group, and approved by the Medical Ethics Committee of our hospital. The approval number was k(2014)28. The written informed consent was signed by every participant before liver fibrosis tests were performed. Inclusion criteria were: 1) patients were admitted to our department; 2) patients were diagnosed with liver cirrhosis; and 3) patients signed the informed consent and agreed to testing of serum liver fibrosis markers (PIIINP, CIV, LN, and HA). Major exclusion criteria were: 1) non-cirrhotic patients; 2) malignancy; and 3) repeated admission.

The participants were prospectively enrolled by our study group (ZMC n=1, YH n=17, XYL n=1, HL n=2, XL n=22, LNR n=14, DW n=6, HZW n=2, JLW n=2, CYW n=10, YLZ n=3, XZ n=3, YGZ n=18, and JJZ n=7). Three researchers (YP, HD, and FFH) recorded the regular clinical and laboratory data of participants from the electronic medical charts of our hospital in the printed case report forms. The primary data at admissions were: age, sex, hepatic encephalopathy, ascites, hydrothorax on chest X ray or CT scans, etiology of liver cirrhosis, red blood cell (RBC), hemoglobin (Hb), white blood cell (WBC), platelets count (PLT), total bilirubin (TBIL), albumin (ALB), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamine transferase (GGT), blood urea nitrogen (BUN), creatinine (Cr), prothrombin time (PT), international normalized ratio (INR), potassium (K), and sodium (Na). Child-Pugh and MELD scores were calculated \[[@b15-medscimonit-22-2720],[@b16-medscimonit-22-2720]\]. Survival condition at the 6^th^ month was obtained by collecting the re-admission and outpatient information in the electronic medical charts and telephone follow-up. Three researchers (XYW, FFH, and XSQ) were responsible for the telephone follow-up. The last telephone follow-up date was April 1, 2016.

As previously mentioned \[[@b17-medscimonit-22-2720],[@b18-medscimonit-22-2720]\], a 3-ml fasting venous blood sample was obtained from every participant and then centrifuged. Two laboratory researchers (JC and CLX) tested the PIIINP, CIV, LN, and HA levels by using the chemiluminescent immunoassay in the LUmo Microplate Luminometer equipment at the lab of our department. The diagnostic kits for the PIIINP, CIV, LN, and HA were provided by the Autobio Diagnostics Co., Ltd. (Zhengzhou, Henan Province, China). According to the directions of diagnostic kits, the reference values were defined by the samples from 546 healthy volunteers. The reference values were: PIIINP \<15 ng/mL, CIV \<95 ng/mL, LN \<130 ng/mL, and HA \<120 ng/mL.

Statistical analyses were performed by using the SPSS and MedCalc software. Categorical data are expressed as frequencies. Continuous data are expressed as means with standard deviations and medians with ranges. Spearman non-parametric tests were employed to test the correlation of PIIINP, CIV, LN, and HA levels with clinical and laboratory data. Logistic regression analysis was used to test the statistically significant prognostic factors. Odds ratio (OR) with 95% confidence interval (CI) was calculated. Receiver operating characteristics (ROC) analysis was used to test the prognostic accuracy. The AUC was calculated and compared by the De Long test. Two-tailed p\<0.05 was considered statistically significant.

Results
=======

Patients characteristics
------------------------

Between January and June 2015, 108 cirrhotic patients were included in this prospective observational study. Patient characteristics are shown in [Table 1](#t1-medscimonit-22-2720){ref-type="table"}. A majority of included patients had hepatitis B virus infection and alcohol abuse as the major etiology of liver cirrhosis. Child-Pugh score was calculated for 104 of them. Mean Child-Pugh score was 7.5±1.9. Eighty-four percent of patients had Child-Pugh classes A and B. MELD score could be calculated in 104 of them. Mean MELD score was 7.1±5.6.

Correlation of serum liver fibrosis markers with clinical and laboratory data
-----------------------------------------------------------------------------

*PIIINP level.* No variables significantly correlated with PIIINP level ([Table 2](#t2-medscimonit-22-2720){ref-type="table"}).

*CIV level.* Ascites, RBC, WBC, TBIL, ALB, ALT, AST, GGT, Na, PT, INR, Child-Pugh score, and MELD score significantly correlated with CIV level ([Table 3](#t3-medscimonit-22-2720){ref-type="table"}).

*LN level.* Ascites, WBC, TBIL, ALB, ALT, AST, ALP, GGT, Na, INR, Child-Pugh score, and MELD score significantly correlated with LN level ([Table 4](#t4-medscimonit-22-2720){ref-type="table"}).

*HA level.* Ascites, hydrothorax, RBC, PLT, TBIL, ALB, PT, INR, Child-Pugh score, and MELD score significantly correlated with HA level ([Table 5](#t5-medscimonit-22-2720){ref-type="table"}).

Prognostic factors
------------------

The 6-month survival data was available in 97 patients. The 6-month mortality was 14.4% (14/97). The logistic regression univariate analysis of factors associated with the 6-month mortality included the absence of ascites (OR=0.184, 95%CI=0.038--0.899, p=0.037) and increased RBC (OR=0.355, 95%CI=0.159--0.795, p= 0.012), TBIL (OR=1.023, 95%CI=1.008--1.039, p=0.003), HA (OR=1.00003, 95%CI=1.000004--1.000056, p=0.022), Child-Pugh score (OR=1.561, 95%CI=1.113--2.152, p=0.007), and MELD score (OR=1.29, 95%CI=1.122--1.483, p\<0.001) ([Table 6](#t6-medscimonit-22-2720){ref-type="table"}).

ROC analysis
------------

The AUC of Child-Pugh score, MELD score, and HA level for predicting the 6-month mortality was 0.692 (95%CI=0.587--0.783, p=0.0276), 0.803 (95%CI=0.707--0.878, p=0.0002), and 0.612 (95%CI=0.508--0.709, p=0.1531), respectively ([Figure 1](#f1-medscimonit-22-2720){ref-type="fig"}). There was a statistically significant difference between Child-Pugh score and HA level (p=0.0124), but there was not a statistically significant difference between Child-Pugh score and HA level (p=0.3421).

Discussion
==========

The present study had 2 primary objectives. The first objective was to validate our previous retrospective observational study regarding the correlation of the 4 serum liver fibrosis markers with the severity of liver dysfunction [@b17-medscimonit-22-2720]. The major similarity and discrepancy are summarized as follows. First, our previous study demonstrated that CIV (coefficient r: 0.2361, p=0.0006), LN (coefficient r: 0.2445, p=0.0004), and HA (coefficient r: 0.1612, p=0.0203) levels significantly correlated with Child-Pugh score, but not PIIINP level (coefficient r: 0.02665, p=0.7031). Similarly, the present prospective observational study confirmed that CIV (coefficient r: 0.658, p\<0.001), LN (coefficient r: 0.450, p\<0.001), and HA (coefficient r: 0.325, p=0.001) levels significantly correlated with Child-Pugh score, but not PIIINP level (coefficient r: 0.081, p=0.414). Second, our previous study also demonstrated that CIV (coefficient r: 0.1795, p=0.0108) and LN (coefficient r: 0.2588, p=0.0002) levels significantly correlated with MELD score, but not PIIINP (coefficient r: 0.04573, p=0.5191) or HA (coefficient r: 0.07926, p=0.2633) level. In contrast, the present study showed that CIV (coefficient r: 0.368, p\<0.001), LN (coefficient r: 0.343, p\<0.001), and HA (coefficient r: 0.282, p=0.004) levels significantly correlated with MELD score, but not PIIINP (coefficient r: 0.090, p=0.363) level. The possible causes for such a discrepancy could be: 1) the patient characteristics were different between the 2 studies; 2) Pearson chi-square test was used in the previous study, but Spearman non-parametric test was used in the present study; and 3) the correlation of HA level with MELD score might be unstable.

The second objective was to explore the effect of the 4 serum liver fibrosis markers on the survival of liver cirrhosis patients. Logistic regression analysis showed that only HA level, but not PIIINP, CIV, or LN level, was significantly associated with the 6-month mortality in cirrhotic patients. However, this association was very weak. When we used the ROC analysis to evaluate the effect of HA level for the predicting the 6-month mortality, the significance disappeared. Indeed, the prognostic value of HA level may be inferior to those of the traditional prognostic models (i.e., Child-Pugh and MELD scores). Therefore, we do not recommend the prognostic values of the 4 serum liver fibrosis markers in liver cirrhosis.

Several limitations of the present study should be mentioned. First, the in-hospital mortality was very low (0.9%, 1/108), and the logistic regression analysis of factors associated with the in-hospital mortality was not performed. Second, the information on 6-month mortality was missing in 11 patients (10.1%, 11/108). Third, long-term follow-up was lacking. Fourth, the causes of admission were heterogeneous.

Conclusions
===========

CIV, LN, and HA levels significantly correlated with the severity of liver dysfunction, but they could not predict the 6-month mortality rate of cirrhotic patients. Therefore, the current evidence does not recommend the prognostic value of serum liver fibrosis markers in liver cirrhosis patients.
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###### 

Patient characteristics.

  Variables                                                     No. Pts available   Mean or frequency   Std. deviation   Median    Minimum   Maximum
  ------------------------------------------------------------- ------------------- ------------------- ---------------- --------- --------- -----------
  Age (years)                                                   108                 59.030              11.498           59.065    26.74     83.16
  Sex (Male/Female) -- n.                                       108                 67/41                                                    
  Hepatic encephalopathy -- n.                                  108                 8                                                        
  Ascites -- n.                                                 108                 63                                                       
  Hydrothorax on chest X ray or CT scans -- n.                  88                  8                                                        
  Etiology of liver cirrhosis -- n.                             108                                                                          
   Hepatitis B virus alone                                                          22                                                       
   Hepatitis C virus alone                                                          7                                                        
   Alcohol alone                                                                    27                                                       
   Drug alone                                                                       4                                                        
   Hepatitis B virus+Alcohol                                                        8                                                        
   Autoimmune                                                                       5                                                        
   Cholestatic                                                                      2                                                        
   Hepatitis B virus+Fatty Liver                                                    1                                                        
   Alcohol+Budd-Chiari Syndrome                                                     1                                                        
   Unknown                                                                          31                                                       
  Red blood cell (10^12^/L)                                     108                 3.239               0.856            3.225     1.38      5.36
  Hemoglobin (g/L)                                              108                 94.148              29.253           93        33        153
  White blood cell (10^9^/L)                                    108                 4.257               2.315            4.1       0.9       15.7
  Platelet (10^9^/L)                                            108                 96.185              62.805           78.5      22        316
  Total bilirubin (umol/L)                                      108                 33.418              36.361           22.65     5.2       234.8
  Albumin (g/L)                                                 107                 31.665              6.276            31.5      16.8      46
  Alanine aminotransferase (U/L)                                108                 35.306              33.980           25        5         249
  Aspartate aminotransferase (U/L)                              108                 48.046              37.442           36        10        227
  Alkaline phosphatase (U/L)                                    108                 123.741             81.544           102.5     24        543
  Gamma-glutamyl transpeptidase (U/L)                           108                 93.046              156.625          50.5      9         1377
  Blood urea nitrogen (mmol/L)                                  106                 6.676               3.645            5.62      1.47      20.46
  Creatinine (umol/L)                                           106                 86.243              133.729          62.45     34.5      1092
  Potassium (mmol/L)                                            108                 3.849               0.584            3.81      2.53      6.13
  Sodium (mmol/L)                                               108                 138.232             4.112            138.9     115.7     144.4
  Prothrombin time (seconds)                                    105                 14.663              3.648            14        10.4      38.8
  International normalized ratio                                105                 1.262               0.313            1.2       0.9       3.37
  Amino-terminal pro-peptide of type III pro-collagen (ng/mL)   108                 31.373              37.246           13.14     2.18      192.35
  IV-collagen (ng/mL)                                           108                 225.882             333.062          149.69    28.79     2990.01
  Laminin (ng/mL)                                               108                 182.016             429.861          92.045    16.09     4184.99
  Hyaluronic acid (ng/mL)                                       108                 5275.794            21185.907        636.885   66.69     145053.94
  Child-Pugh score                                              104                 7.538               1.920            7         5         12
  Child-Pugh class -- n.                                        104                                                                          
   A                                                                                33                                                       
   B                                                                                55                                                       
   C                                                                                16                                                       
  Model for end stage liver diseases (MELD) score               104                 7.106               5.588            6.672     −3.16     31.4

###### 

Correlation of PIIINP with clinical and laboratory data by Spearman non-parametric tests.

  Variables                                         No. Pts available   Correlation coefficient   Sig. (2-tailed)
  ------------------------------------------------- ------------------- ------------------------- -----------------
  Age                                               108                 0.028                     0.771
  Sex                                               108                 −0.047                    0.628
  Hepatic encephalopathy                            108                 0.079                     0.414
  Ascites                                           108                 0.046                     0.636
  Hydrothorax on chest X ray or CT scans            88                  0.114                     0.292
  Red blood cell                                    108                 0.014                     0.890
  Hemoglobin                                        108                 0.055                     0.574
  White blood cell                                  108                 0.133                     0.170
  Platelet                                          108                 −0.075                    0.443
  Total bilirubin                                   108                 0.074                     0.448
  Albumin                                           107                 −0.122                    0.212
  Alanine aminotransferase                          108                 −0.019                    0.843
  Aspartate aminotransferase                        108                 −0.016                    0.871
  Alkaline phosphatase                              108                 −0.113                    0.246
  Gamma-glutamyl transpeptidase                     108                 0.006                     0.955
  Blood urea nitrogen                               106                 −0.018                    0.858
  Creatinine                                        106                 0.038                     0.700
  Potassium                                         108                 −0.047                    0.629
  Sodium                                            108                 −0.058                    0.554
  Prothrombin time                                  105                 0.019                     0.844
  International normalized ratio                    105                 0.065                     0.512
  Child-Pugh score                                  104                 0.081                     0.414
  Model for end stage liver diseases (MELD) score   104                 0.090                     0.363

###### 

Correlation of CIV with clinical and laboratory data by Spearman non-parametric tests.

  Variables                                         No. Pts available   Correlation coefficient   Sig. (2-tailed)
  ------------------------------------------------- ------------------- ------------------------- -----------------
  Age                                               108                 0.063                     0.519
  Sex                                               108                 −0.126                    0.192
  Hepatic encephalopathy                            108                 0.027                     0.78
  Ascites                                           108                 0.438                     **\<0.001**
  Hydrothorax on chest X ray or CT scans            88                  0.204                     0.057
  Red blood cell                                    108                 −0.225                    **0.019**
  Hemoglobin                                        108                 −0.073                    0.453
  White blood cell                                  108                 0.225                     **0.019**
  Platelet                                          108                 −0.131                    0.176
  Total bilirubin                                   108                 0.434                     **\<0.001**
  Albumin                                           107                 −0.567                    **\<0.001**
  Alanine aminotransferase                          108                 0.235                     **0.014**
  Aspartate aminotransferase                        108                 0.321                     **0.001**
  Alkaline phosphatase                              108                 0.174                     0.072
  Gamma-glutamyl transpeptidase                     108                 0.289                     **0.002**
  Blood urea nitrogen                               106                 −0.074                    0.453
  Creatinine                                        106                 0.026                     0.793
  Potassium                                         108                 −0.212                    0.028
  Sodium                                            108                 −0.339                    **\<0.001**
  Prothrombin time                                  105                 0.356                     **\<0.001**
  International normalized ratio                    105                 0.37                      **\<0.001**
  Child-Pugh score                                  104                 0.658                     **\<0.001**
  Model for end stage liver diseases (MELD) score   104                 0.368                     **\<0.001**

###### 

Correlation of LN with clinical and laboratory data by Spearman non-parametric tests.

  Variables                                         No. Pts available   Correlation coefficient   Sig. (2-tailed)
  ------------------------------------------------- ------------------- ------------------------- -----------------
  Age                                               108                 0.059                     0.544
  Sex                                               108                 0.022                     0.821
  Hepatic encephalopathy                            108                 0.100                     0.301
  Ascites                                           108                 0.296                     **0.002**
  Hydrothorax on chest X ray or CT scans            88                  0.178                     0.097
  Red blood cell                                    108                 0.050                     0.609
  Hemoglobin                                        108                 0.173                     0.073
  White blood cell                                  108                 0.268                     **0.005**
  Platelet                                          108                 −0.015                    0.881
  Total bilirubin                                   108                 0.461                     **\<0.001**
  Albumin                                           107                 −0.324                    **0.001**
  Alanine aminotransferase                          108                 0.298                     **0.002**
  Aspartate aminotransferase                        108                 0.421                     **\<0.001**
  Alkaline phosphatase                              108                 0.232                     **0.016**
  Gamma-glutamyl transpeptidase                     108                 0.254                     **0.008**
  Blood urea nitrogen                               106                 −0.179                    0.066
  Creatinine                                        106                 0.060                     0.543
  Potassium                                         108                 −0.158                    0.102
  Sodium                                            108                 −0.238                    **0.013**
  Prothrombin time                                  105                 0.153                     0.120
  International normalized ratio                    105                 0.199                     **0.041**
  Child-Pugh score                                  104                 0.450                     **\<0.001**
  Model for end stage liver diseases (MELD) score   104                 0.343                     **\<0.001**

###### 

Correlation of HA with clinical and laboratory data by Spearman non-parametric tests.

  Variables                                         No. Pts available   Correlation coefficient   Sig. (2-tailed)
  ------------------------------------------------- ------------------- ------------------------- -----------------
  Age                                               108                 0.062                     0.525
  Sex                                               108                 −0.038                    0.694
  Hepatic encephalopathy                            108                 0.164                     0.089
  Ascites                                           108                 0.300                     **0.002**
  Hydrothorax on chest X ray or CT scans            88                  0.274                     **0.010**
  Red blood cell                                    108                 −0.258                    **0.007**
  Hemoglobin                                        108                 −0.104                    0.286
  White blood cell                                  108                 0.000                     1.000
  Platelet                                          108                 −0.268                    **0.005**
  Total bilirubin                                   108                 0.240                     **0.012**
  Albumin                                           107                 −0.248                    **0.010**
  Alanine aminotransferase                          108                 0.046                     0.636
  Aspartate aminotransferase                        108                 0.041                     0.671
  Alkaline phosphatase                              108                 −0.060                    0.536
  Gamma-glutamyl transpeptidase                     108                 0.075                     0.442
  Blood urea nitrogen                               106                 0.004                     0.965
  Creatinine                                        106                 0.144                     0.141
  Potassium                                         108                 −0.180                    0.062
  Sodium                                            108                 −0.022                    0.824
  Prothrombin time                                  105                 0.239                     **0.014**
  International normalized ratio                    105                 0.229                     **0.019**
  Child-Pugh score                                  104                 0.325                     **0.001**
  Model for end stage liver diseases (MELD) score   104                 0.282                     **0.004**

###### 

Logistics regression analysis of factors associated with 6-month death.

  Variables                                               No. Pts available   6-month death *vs.* alive   P value   OR        95%CI
  ------------------------------------------------------- ------------------- --------------------------- --------- --------- --------------------
  Age                                                     97                  14 *vs.* 83                 0.237     1.031     0.980--1.085
  Sex (Male *vs.* Female)                                 97 (57 *vs.* 40)    14 *vs.* 83                 0.894     0.925     0.294--2.908
  Hepatic encephalopathy (No *vs.* Yes)                   97 (91 *vs.* 6)     14 *vs.* 83                 0.999     2.937     NA
  Ascites (No *vs.* Yes)                                  97 (39 *vs.* 58)    14 *vs.* 83                 0.037     0.184     0.038--0.899
  Hydrothorax on chest X ray or CT scans (No *vs.* Yes)   79 (72 *vs.* 7)     11 *vs.* 68                 0.258     0.357     0.060--2.123
  Red blood cell                                          97                  14 *vs.* 83                 0.012     0.355     0.159--0.795
  Hemoglobin                                              97                  14 *vs.* 83                 0.062     0.980     0.959--1.001
  White blood cell                                        97                  14 *vs.* 83                 0.99      0.998     0.775--1.285
  Platelet                                                97                  14 *vs.* 83                 0.93      1.000     0.992--1.009
  Total bilirubin                                         97                  14 *vs.* 83                 0.003     1.023     1.008--1.039
  Albumin                                                 96                  14 *vs.* 82                 0.08      0.916     0.831--1.011
  Alanine aminotransferase                                97                  14 *vs.* 83                 0.57      0.993     0.971--1.016
  Aspartate aminotransferase                              97                  14 *vs.* 83                 0.996     1.000     0.985--1.015
  Alkaline phosphatase                                    97                  14 *vs.* 83                 0.488     1.002     0.996--1.008
  Gamma-glutamyl transpeptidase                           97                  14 *vs.* 83                 0.424     0.997     0.989--1.005
  Blood urea nitrogen                                     95                  14 *vs.* 81                 0.102     1.121     0.978--1.286
  Creatinine                                              93                  13 *vs.* 80                 0.111     1.002     0.999--1.006
  Potassium                                               97                  14 *vs.* 83                 0.075     0.338     0.103--1.114
  Sodium                                                  97                  14 *vs.* 83                 0.069     0.896     0.795--1.009
  Prothrombin time                                        94                  14 *vs.* 80                 0.161     1.093     0.965--1.237
  International normalized ratio                          94                  14 *vs.* 80                 0.128     3.084     0.723--13.155
  Amino-terminal pro-peptide of type III pro-collagen     97                  14 *vs.* 83                 0.265     1.007     0.995--1.020
  IV-collagen                                             97                  14 *vs.* 83                 0.235     1.001     0.999--1.004
  Laminin                                                 97                  14 *vs.* 83                 0.899     1.000     0.999--1.001
  Hyaluronic acid                                         97                  14 *vs.* 83                 0.022     1.00003   1.000004--1.000056
  Child-Pugh score                                        93                  14 *vs.* 79                 0.007     1.561     1.113--2.152
  Model for end stage liver diseases (MELD) score         93                  14 *vs.* 79                 \<0.001   1.290     1.122--1.483
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